Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells

British Journal of Cancer

Volumn 111, Issue 1, 2014, Pages 149-156

  Kraan, J ^a   Van Den Broek, P ^a   Verhoef, C ^a   Grunhagen, D J ^a   Taal, W ^a   Gratama, J W ^a   Sleijfer, S ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

Author keywords

CD276; circulating endothelial cells (CEC); endothelial cells; flowytometry; pericytes; rare events; tumour endothelial markers (TEM)

Indexed keywords

ANTIGEN; B7 H3 ANTIGEN; CD109 ANTIGEN; CD137 ANTIGEN; CD141 ANTIGEN; CD146 ANTIGEN; CD276 ANTIGEN; CD309 ANTIGEN; CHEMOKINE RECEPTOR CXCR7; ENDOGLIN; INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ADVANCED CANCER; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER PATIENT; CELL COUNT; CIRCULATING ENDOTHELIAL CELL; CIRCULATING TUMOR CELL; COLORECTAL CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; PERICYTE; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

B7 ANTIGENS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; TUMOR MARKERS, BIOLOGICAL;

EID: 84904129269     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.286     Document Type: Article

References (36)

1. Bertolini F, Mancuso P, Shaked Y, Kerbel RS (2007) Molecular and cellular biomarkers for angiogenesis in clinical oncology. Drug Discov Today 12: 806-812.
2. Broll K, Richter G, Pauly S, Hofstaedter F, Schwarz H (2001) CD137 expression in tumor vessel walls. High correlation with malignant tumors. Am J Clin Pathol 115: 543-549.
3. Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473: 298-307.
4. Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, Chen L (2001) B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2: 269-274.
5. Crisan M, Yap S, Casteilla L, Chen CW, CorselliM, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J, Peault B (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301-313.
6. Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich BC, Blute ML, Kwon ED (2008) Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res 14: 5150-5157.
7. Dignat-George F, Sabatier F, Blann A, Woywodt A (2007) Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay? J Clin Oncol 25: E1-e2; author reply e3-5.
8. Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: Evidence and potential applications. FASEB J 17: 984-992.
9. Goon PK, Boos CJ, Stonelake PS, Blann AD, Lip GY (2006) Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: A methodological comparison. Thromb Haemost 96: 45-52.
10. Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G (1996) Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: The role of angiogenic factors. Cancer Res 56: 1111-1117.
11. Hagendoorn J, Tong R, Fukumura D, Lin Q, Lobo J, Padera TP, Xu L, Kucherlapati R, Jain RK (2006) Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. Cancer Res 66: 3360-3364.
12. Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC, Klagsbrun M (2004) Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 64: 8249-8255.
13. Kraan J, Sleijfer S, Foekens JA, Gratama JW (2012a) Clinical value of circulating endothelial cell detection in oncology. Drug Discov Today 17: 710-717.
14. Kraan J, Strijbos MH, Sieuwerts AM, Foekens JA, den Bakker MA, Verhoef C, Sleijfer S, Gratama JW (2012b) A new approach for rapid and reliable enumeration of circulating endothelial cells in patients. J Thromb Haemost 10: 931-939.
15. Lemke D, Pfenning PN, Sahm F, Klein AC, Kempf T,Warnken U, Schnolzer M, Tudoran R, Weller M, Platten M, Wick W (2012) Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness. Clin Cancer Res 18: 105-117.
16. Lijnen HR, Lupu F, Collen D, Le Naour F, Boucheix C (2000) CD9 gene deficiency does not affect smooth muscle cell migration and neointima formation after vascular injury in mice. Thromb Haemost 83: 956-961.
17. Maishi N, Ohga N, Hida Y, Akiyama K, Kitayama K, Osawa T, Onodera Y, Shinohara N, Nonomura K, Shindoh M, Hida K (2012) CXCR7: A novel tumor endothelial marker in renal cell carcinoma. Pathol Int 62: 309-317.
18. McDonald DM, Choyke PL (2003) Imaging of angiogenesis: From microscope to clinic. Nat Med 9: 713-725.
19. Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O (2006) Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int 56: 717-723.
20. Nagy JA, Chang SH, Shih SC, Dvorak AM, Dvorak HF (2010) Heterogeneity of the tumor vasculature. Semin Thromb Hemost 36: 321-331.
21. Naumov GN, Bender E, Zurakowski D, Kang SY, Sampson D, Flynn E, Watnick RS, Straume O, Akslen LA, Folkman J, Almog N (2006) A model of human tumor dormancy: An angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst 98: 316-325.
22. Ouhtit A, Gaur RL, Abd Elmageed ZY, Fernando A, Thouta R, Trappey AK, Abdraboh ME, El-Sayyad HI, Rao P, Raj MG (2009) Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. Biochim Biophys Acta 1795: 130-136.
23. Plate KH, Breier G, Millauer B, Ullrich A, Risau W (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53: 5822-5827.
24. Qin X, Zhang H, Ye D, Dai B, Zhu Y, Shi G (2013) B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma. Onco Targets Ther 6: 1667-1673.
25. Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML, Cheville JC, Sebo TJ, Kwon ED (2007) B7-H3 ligand expression by prostate cancer: A novel marker of prognosis and potential target for therapy. Cancer Res 67: 7893-7900.
26. Rowand JL, Martin G, Doyle GV, Miller MC, Pierce MS, Connelly MC, Rao C, Terstappen LW (2007) Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry A 71: 105-113.
27. Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, Croix St B (2007) Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11: 539-554.
28. Croix St B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW (2000) Genes expressed in human tumor endothelium. Science 289: 1197-1202.
29. Steinberger P, Majdic O, Derdak SV, Pfistershammer K, Kirchberger S, Klauser C, Zlabinger G, Pickl WF, Stockl J, Knapp W (2004) Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol 172: 2352-2359.
30. Strijbos MH, Gratama JW, Kraan J, Lamers CH, den Bakker MA, Sleijfer S (2008) Circulating endothelial cells in oncology: Pitfalls and promises. Br J Cancer 98: 1731-1735.
31. Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK, Wang X (2006) B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 53: 143-151.
32. Wurth R, Barbieri F, Bajetto A, Pattarozzi A, Gatti M, Porcile C, Zona G, Ravetti JL, Spaziante R, Florio T (2011) Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature. J Neuroimmunol 234: 115-123.
33. Xiong YQ, Sun HC, Zhang W, Zhu XD, Zhuang PY, Zhang JB, Wang L, Wu WZ, Qin LX, Tang ZY (2009) Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Clin Cancer Res 15: 4838-4846.
34. Yamato I, Sho M, Nomi T, Akahori T, Shimada K, Hotta K, Kanehiro H, Konishi N, Yagita H, Nakajima Y (2009) Clinical importance of B7-H3 expression in human pancreatic cancer. Br J Cancer 101: 1709-1716.
35. Zang X, Sullivan PS, Soslow RA, Waitz R, Reuter VE, Wilton A, Thaler HT, Arul M, Slovin SF, Wei J, Spriggs DR, Dupont J, Allison JP (2010) Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas. Mod Pathol 23: 1104-1112.
36. Zimmerlin L, Donnenberg VS, Pfeifer ME, Meyer EM, Peault B, Rubin JP, Donnenberg AD (2010) Stromal vascular progenitors in adult human adipose tissue. Cytometry A 77: 22-30.